Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$396.00K$396.00Kderived+100.0% vs Q4 2017 Net Income-$2.29M-$2.29MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$240,000+154.9% Operating Incomederived-$1,517,000N/M Operating Cash Flowderived-$840,000N/M Margins · derivedGross margin60.6%+13.0 pt vs Q4 2017
Operating margin-383.1%+373.4 pt vs Q4 2017
Net margin-577.8%+635.1 pt vs Q4 2017
ended Dec 31, 2018 · filed Mar 29, 2019 · 88 d after period end